Pfizer surprises industry by ending development of projected blockbuster
November 1, 2016Research and Development Pfizer, cholesterol, clinical trials
Pfizer announced the news that it would no longer be developing an experimental cholesterol lowering drug. The drug had been …
FDA approves clinical trial of Cuban lung cancer vaccine
November 1, 2016Manufacturing and Production, Sales and Marketing Cuba, US, Vaccine, cimavax, clinical trials
The thawing of relations between the US and Cuba has allowed a pioneering treatment for non-small cell lung cancer to …
EMA has validated Merck and Pfizer’s MAA for avelumab
November 1, 2016Manufacturing and Production, Sales and Marketing EMA, Merck KGaA, Pfizer, avelumab
The European Medicines Agency has validated the Marketing Authorisation Application for avelumab for the proposed indication of metastatic Merkel cell …
Woodley Equipment Company Exhibiting at Partnerships in Clinical Trials Europe 2016
November 1, 2016PCT, clinical trials
Woodley Equipment Company is exhibiting at Partnerships in Clinical Trials Europe
Promising new study for children’s brain cancer
November 1, 2016Manufacturing and Production brain cancer, children, oncology
There has been positive news coming from researchers at the Huntsman Cancer Institute, at the University of Utah, reporting on …
Hard times continue for Valeant as ex-CEO investigated for fraud
November 1, 2016Manufacturing and Production CEO, Valeant, Valeant Pharmaceuticals, accounting, fraud
Valeant Pharmaceuticals continues to have a tough time after Bloomsberg broke the story of how former CEO J. Michael Pearson …
Novartis breast cancer drug secures FDA fast-track status
November 1, 2016Manufacturing and Production, Sales and Marketing Novartis, Pfizer, ibrance, letrozole, riboclib
Novartis has announced that its product ribociclib (LEE011) has been granted fast-track review status as a first-line treatment of advanced …
Takeda appoint Marc Weeks to Digital Lead role
October 31, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, digital
Takeda UK have appointed Marc Weeks to the newly created role of digital lead. The creation of the role comes as …
Ashfield walks away with gold at EVCOM Clarion Awards
October 31, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield
The awards ceremony, held at The Seven Dials Club, Covent Garden, London on Friday 7 October, drew leading event and …
Influenza vaccine market to grow to £4.3 billion by 2025
October 31, 2016Sales and Marketing influenza
GlobalData has released new findings which indicate that the seasonal influenza vaccine market is set to be worth $4.3 billion …
FDA rejects Sarilumab due to production facility issues
October 31, 2016Manufacturing and Production, Sales and Marketing FDA, Regeneron, Sanofi, sarilumab
The US Food and Drugs administration has decided to reject the application for Sarilumab, Regeneron and Sanofi’s rheumatoid arthritis treatment, …
Teva sets out to delay generic competitor to Copaxone
October 31, 2016Sales and Marketing Copaxone, Teva, Teva Pharmaceutical, generics
Teva Pharmacetuical, the Israel-based pharmaceutical company, submitted a document to the FDA on 30 October; the document outlines the differences …
Astellas snatches up oncology firm Ganymed for $1.4 billion
October 31, 2016Research and Development, Sales and Marketing Astellas, Ganymed, IMAB362
Japanese pharma firm Astellas is set to bolster its oncology business with the acquisition of Ganymed Pharmaceuticals in a deal …
AstraZeneca’s head and neck cancer treatment clinical trials put on hold
October 31, 2016Sales and Marketing AstraZeneca, clinical hold, clinical trials, immunotherapy, phase III
AstraZeneca, the Cambridge-based British company, had recruitment for its final stage Phase III trials placed on partial hold. The drug …
Novartis elects new MD for UK plant
October 28, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, appointment
Novartis has named Cynthia Chiaramitara as managing director of its plant in Grimsby, UK. She will take on the role …
Allergan in $200 million purchase of biopharmaceutical
October 28, 2016Medical Communications Allergan, Motus Therapeutics, Rythm Holding, Teva
Allergan will acquire Motus Therapeautics, a biopharmaceutical company that specialises in developing treatments for gastroparesis. It is another acquisition that …
Top ten stories in the pharmaceutical industry this week
October 28, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Halloween is creeping up, and its business as usual for the pharma industry; the week has been full of shockers, …
BMS unveils reorganisation plans & boosted profits
October 28, 2016Business Services, Medical Communications Bristol-Myers Squibb, Yervoy, opdivo
BMS has announced its intention to restructure its operations alongside $3 billion share buyback and quarterly results which exceeded expectations.The …
Male birth control injection has high efficacy but side-effects halt trials
October 28, 2016Medical Communications WHO, birth control, male contraceptive, pregnancies
The study, funded by the World Health Organization, found a jab was close to 96% effective in tests to ascertain …
J&J pays $70m over cancer allegations
October 28, 2016Medical Communications JJohnson & Johnson, ovarian cancer
Johnson & Johnson has been forced to pay out $70 million after it was alleged that years of using the …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
